- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Stocks: 10 Biggest Companies
Investors have diverse choices when it comes to cannabis stocks. Here's a look at the largest players in the sector and their operations.
The cannabis industry faced similar obstacles in 2023 as it did in 2022, with a lack of reform in both the US and Canada proving to be a significant roadblock to growth in the market.
Even so, companies in the sector continue to move forward, and with potential catalysts ahead some investors are interested in getting involved. Looking at key players is often a good place to get started.
This list was put together based on the top-weighted pure cannabis stocks included in the AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) and the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) as of November 30, 2023. Share price information for the companies was accurate as of that time.
US operators
Cannabis is federally illegal in the US, but state market openings have allowed some operators to thrive. Typically these firms set up vertically integrated businesses with a focus on branded products, retail networks and licenses.
While these companies have adapted to regulatory challenges, they have much to gain from country-level reform in the US, and are eager to see more welcoming federal laws that will allow their businesses to develop further.
US-focused cannabis fund
The AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) provides exposure to companies exclusively operating within the US cannabis industry. By investing in companies that are working in states with clear guidelines, MSOS gives investors a way to be more selective about the types of cannabis companies they're investing in.
MSOS has decreased in value by 0.73 percent in 2023, reaching US$6.82 as of November 30.
1. Green Thumb Industries (CSE:GTII,OTCQX:GTBIF)
ETF weight: 25.94 percent; market cap: US$2.48 billion; current share price: US$10.48
Green Thumb Industries is a multi-state operator (MSO) with headquarters in Chicago, Illinois. The company produces and sells cannabis products for recreational and medical use out of 87 stores across 15 states.
The third quarter of 2023 was a significant period for Green Thumb, which reported revenue of US$275 million, up 9 percent quarter-on-quarter, and GAAP net income of US$11 million. The company attributes this growth to the start of adult-use sales at its four cannabis shops in Maryland following legalization in the state on July 1.
2. Curaleaf Holdings (CSE:CURA,OTCQX:CURLF)
ETF weight: 19.33 percent; market cap: US$2.66 billion; current share price: US$3.77
Curaleaf Holdings has a significant presence in the US cannabis market, with 146 dispensaries and 21 cultivation centers in 18 states. The company is also continuing its expansion into the European cannabis sector, where it already has a strong presence. Curaleaf applied to uplist to the TSX on October 10 and is awaiting approval.
Curaleaf is one of many US companies that is optimizing its operations to cope with cannabis industry challenges. Q3 saw Curaleaf complete the final steps of its asset optimization plan, which included reducing inventory and adding new product offerings. The company’s third quarter results show revenue of US$333 million, representing a year-on-year increase of 2 percent, and an adjusted EBITDA margin of 23 percent. In a statement released alongside the results, Executive Chairman Boris Jordan said he was “pleased that (Curaleaf’s) changes are showing results.”
3. Verano Holdings (NEO:VRNO,OTCQX:VRNOF)
ETF weight: 14.64 percent; market cap US$1.02 billion; current share price: US$5.50
Verano Holdings is a vertically integrated cannabis company. It delivers high-quality products out of its 136 Zen Leaf and MÜV retail locations, which are spread across 13 states. The company reported Q3 revenue of US$240 million, which represents year-on-year growth of 5 percent; of its revenue, 67 percent was retail and 33 percent was wholesale.
Verano recently moved from the CSE to Cboe Canada, which is the new business name of the NEO Exchange. The move is expected to increase the company's visibility and accessibility to investors, while leaving it in a better position to transition to a US exchange if cannabis is legalized there, according to CEO George Archos.
4. Trulieve Cannabis (CSE:TRUL,OTCQX:TCNNF)
ETF weight: 11.9 percent; market cap: US$1.02 billion; current share price: US$5.50
Vertically integrated medical cannabis firm Truelieve Cannabis has a dominant market share in its home state of Florida.
Trulieve recently announced that it would be redeeming its 9.75 percent senior secured notes, worth US$130 million, on December 1, six months ahead of the original due date in June 2024. This comes on the heels of a strong third quarter for the company, with retail sales accounting for 96 percent of its total revenue of US$275 million.
5. TerrAscend (CSE:TER,OTCQX:TRSSF)
ETF weight: 6.89 percent; market cap: US$558.69 million; current share price: US$1.67
TerrAscend is a vertically integrated MSO with operations in the US as well as Canada. Its diversified ownership structure is a good representation of the growing interest in the cannabis industry from various sources.
TerrAscend has 37 dispensaries in five states, including six medical dispensaries in Pennsylvania and four in Maryland, where adult-use recreational cannabis became legal this year. TerrAscend also has a strong presence in New Jersey, with retail stores and a state-of-the-art cultivation and production facility. The Garden State is the company’s most profitable market, and the company’s third quarter report reveals that during the period it climbed to second place in terms of market share in the state at 18.6 percent — that's less than 1 percent from the top spot.
TerrAscend’s Q3 net revenue was up 34.7 percent year-on-year in Q3, jumping to a record US$89.2 million.
Canadian growers
In 2018, Canada became the first G7 nation to legalize adult-use cannabis and create its own streamlined program regulated by both federal and provincial powers. Since then, companies working in the country have faced ups and downs in dealing with tight marketing rules, high tax rates and ongoing competition with the unregulated market.
Canada-based cannabis fund
The Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) was the first cannabis ETF available in Canada, and it holds a variety of companies involved in cannabis, along with several non-flower companies.
While HMMJ does not invest in US-based MSOs, it does have exposure to the US market through Canadian companies that have interests in the US cannabis industry. Overall, HMMJ is designed to give investors broad exposure to the cannabis industry, with a particular focus on North American companies.
This ETF had a year-to-date loss of 27.16 percent as of November 30 and a price point of US$8.61.
1. Innovative Industrial Properties (NYSE:IIPR)
ETF weight: 15.72 percent; market cap: US$2.24 billion; current share price: US$25.82
Innovative Industrial Properties is a real estate investment trust that provides specialized real estate opportunities for cannabis companies in 19 states. Its properties mostly consist of processing plants, greenhouses and warehouses, with retail spaces making up a small percentage of its portfolio.
The firm has provided long-term absolute net lease agreements to some of the cannabis industry’s biggest names, including Green Thumb, Tilt Holdings (NEO:TILT,OTCQB:TLLTF), Ascend Wellness (CSE:AAWH.U,OTCQX:AAWH) and Curaleaf. The company’s attractive sale-leaseback program has helped cannabis companies access a source of capital, a much-needed workaround in the US where there are fewer traditional financing options.
2. Cronos Group (NASDAQ:CRON,TSX:CRON)
ETF weight: 14.73 percent; market cap: US$744.1 million; current share price: US$1.95
Cronos Group is the Canada-based company behind the Spinach, Peace Naturals and Lord Jones cannabis brands. The company recently re-entered the German medical cannabis market through its partnership with a German medical cannabis company called Cansativa Group, and is positioned to take advantage of potential adult-use legalization in the country. Cronos also serves the Israeli market through its subsidiary Cronos Israel.
The company’s Q3 results reveal a 22 percent year-on-year net revenue increase, marking one of the “best quarters in Cronos history,” according to Mike Gorenstein, the chairman, president and CEO of the company. Gorenstein also mentions in the press release that his company recently agreed to start sending cannabis products to Vitura Health for sale in Australia, further expanding its global reach.
3. Tilray Brands (NASDAQ:TLRY,TSX:TLRY)
ETF weight: 11.22 percent; market cap: US$1.29 billion; share price: US$1.77
Tilray Brands has a presence in over 20 countries worldwide with a wide range of cannabis products, including edibles, flower and oils. The company solidified its position as one of the largest players in the global cannabis market after it merged with medical cannabis brand Aphria in 2020. This past June, Tilray acquired cannabis company HEXO — a move that contributed to a 6 percent year-on-year increase in total revenue on a constant-currency basis.
The bulk of Tilray’s sales lies in the Canadian and international medical cannabis export markets. The company has a relatively small presence in the US and is limited to selling products infused only with CBD.
4. SNDL (NASDAQ:SNDL)
ETF weight: 5.46 percent; market cap: US$366.97 million; current share price: US$1.41
SNDL, formerly known as Sundial Growers, is the largest private sector liquor and cannabis retailer on the Canadian market. The company has made the headlines quite frequently throughout 2023, notably in October, when it chose to close its Olds, Alberta, cannabis facility. Its share price has fallen more than 40 percent over the course of the year, but the steps the company has taken to reduce its debt and the introduction of new products to the SNDL lineup resulted in positive free cash flow of US$16.5 million in the third quarter, a 147.5 percent increase from Q3 2022.
The company also reported net revenue of US$75.5 million for cannabis retail, an increase of 14.1 percent compared to 2022, and net revenue of US$21 million for cannabis operations, a 77.4 percent increase over the same period.
5. Canopy Growth (NASDAQ:CGC,TSX:WEED)
ETF weight: 3.88 percent; market cap: US$447.96 million; current share price: US$0.54
Canopy Growth is a company that’s grown alongside Canada’s cannabis industry. Founded in 2013, it has become one of the largest producers of cannabis in the world, fostering brand deals with celebrities like Martha Stewart and Snoop Dogg.
The company released positive results for its second fiscal quarter of 2024 on November 9, indicating that it is on track for another profitable year, despite the setbacks faced by many in the cannabis industry.
“Our financial results demonstrated marked improvement this quarter, including significant gross margin gains and reduced cash burn. This enhanced performance, together with a series of completed balance sheet strengthening actions, has solidified our foundation and set the stage for profitable growth ahead,” said CFO Judy Hong.
FAQs for investing in cannabis
Are cannabis stocks worth investing in?
Each investor will have to think and act for themselves to manage their own risk exposure, but it’s no secret that cannabis stocks have taken a beating for some time now. While financial experts point to the long-term upside of US operators as more state markets expand, the stock market has not been kind to these names lately.
Are cannabis stocks considered a high- or low-risk investment?
Cannabis investments are extremely young in the grand scheme of the investment universe. There is an exciting and refreshing element to these stocks, but the market has always been characterized by volatility and unpredictability.
While wild, spontaneous swings in the open market have become less common, cannabis stocks are often moved — both positively and negatively — by big pieces of market news or legalization updates.
Why do people buy cannabis stocks?
Investors may choose to get exposure to the cannabis market as a way to participate in the development of a new drug market with consumer packaged goods capabilities. Some participants are bullish on the industry's long-term outlook and expect more welcoming laws in the US and across the world to provide upward momentum.
Don’t forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
- Cannabis Market Forecast: Top Trends That Will Affect Cannabis in 2024 ›
- Cannabis Market 2023 Year-End Review ›
- ASX Cannabis Stocks: 10 Biggest Companies in 2023 ›
- How to Invest in a Cannabis Stock ›
Meagen moved to Vancouver in 2019 after splitting her time between Australia and Southeast Asia for three years. She worked simultaneously as a freelancer and childcare provider before landing her role as an Investment Market Content Specialist at the Investing News Network.
Meagen has studied marketing, developmental and cognitive psychology and anthropology, and honed her craft of writing at Langara College. She is currently pursuing a degree in psychology and linguistics. Meagen loves writing about the life science, cannabis, tech and psychedelics markets. In her free time, she enjoys gardening, cooking, traveling, doing anything outdoors and reading.
Outlook Reports
Featured Cannabis Investing News Stocks
Browse Companies
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 2342.62 | +11.97 | |
Silver | 27.49 | +0.14 | |
Copper | 4.59 | +0.05 | |
Oil | 84.35 | +0.78 | |
Heating Oil | 2.59 | +0.03 | |
Natural Gas | 1.53 | -0.11 |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Meagen moved to Vancouver in 2019 after splitting her time between Australia and Southeast Asia for three years. She worked simultaneously as a freelancer and childcare provider before landing her role as an Investment Market Content Specialist at the Investing News Network.
Meagen has studied marketing, developmental and cognitive psychology and anthropology, and honed her craft of writing at Langara College. She is currently pursuing a degree in psychology and linguistics. Meagen loves writing about the life science, cannabis, tech and psychedelics markets. In her free time, she enjoys gardening, cooking, traveling, doing anything outdoors and reading.
Learn about our editorial policies.